|
TAF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.45260003814718E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45159995135202E-09 |
| Normal-vs-Stage2 |
3.136600E-03 |
| Normal-vs-Stage3 |
5.416300E-02 |
| Normal-vs-Stage4 |
6.573600E-02 |
| Stage1-vs-Stage2 |
4.972400E-01 |
| Stage1-vs-Stage3 |
5.893600E-02 |
| Stage1-vs-Stage4 |
4.537000E-01 |
| Stage2-vs-Stage3 |
4.081200E-01 |
| Stage2-vs-Stage4 |
8.144400E-01 |
| Stage3-vs-Stage4 |
6.674800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.81079995232159E-09 |
| Normal-vs-AfricanAmerican |
9.02679999970069E-07 |
| Normal-vs-Asian |
5.103800E-01 |
| Caucasian-vs-AfricanAmerican |
7.451000E-01 |
| Caucasian-vs-Asian |
3.647600E-01 |
| AfricanAmerican-vs-Asian |
3.303600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.14430037562374E-10 |
| Normal-vs-Female |
3.116900E-03 |
| Male-vs-Female |
1.805790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.53150000000402E-05 |
| Normal-vs-Extreme_Weight |
1.49770196244958E-11 |
| Normal-vs-Obese |
1.049070E-04 |
| Normal-vs-Extreme_Obese |
4.364100E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.664620E-01 |
| Normal_Weight-vs-Obese |
5.220200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.023200E-01 |
| Extreme_Weight-vs-Obese |
1.743510E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.971600E-01 |
| Obese-vs-Extreme_Obese |
2.676000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.028400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.53989999996629E-07 |
| Normal-vs-Age(61-80Yrs) |
1.17800003085478E-09 |
| Normal-vs-Age(81-100Yrs) |
8.22179999970807E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.537040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.932200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.604200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.154600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.274440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.469800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.53990051213293E-10 |
| Normal-VS-Type2 PRCC |
3.6228000000027E-05 |
| Normal-VS-KIRP CIMP |
6.338400E-01 |
| Normal-VS-Unclassified PRCC |
3.319500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.724200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.973900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.525570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.704820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.560200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.744800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6904999999845E-07 |
| Normal-vs-N1 |
4.451600E-01 |
| Normal-vs-N2 |
3.329400E-01 |
| N0-vs-N1 |
9.397300E-03 |
| N0-vs-N2 |
7.575800E-01 |
| N1-vs-N2 |
4.368000E-01 |
|
|
